24 May 2013
Keywords: Amarin, Ethyl Eicosapent, EMEA, MA withdrawal, Huntington's disease
Article | 09 December 2009
The European Medicines Agency (EMEA) says it has been formally notified by Ireland-based Amarin Neuroscience of its decision to withdraw ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 December 2009
23 May 2013
© 2013 thepharmaletter.com